PCRX (Pacira BioSciences) Short-Term Debt to Capital

Corporate company logo of Pacira BioSciences (PCRX)

This price evolution chart demonstrates the price action of Pacira BioSciences (PCRX), where the indicator stands at 0.00. The business relies on partnerships with clinics to implement comfortable recovery methodologies. Success is bolstered by its image as a reliable manufacturer of safe pain management products. Meanwhile, Pacira BioSciences (PCRX) protects its liposomal developments with patents, although it faces the risk of generic competitors entering the market.

Ratio of Short-Term Indebtedness to Capital: Pacira (PCRX) for 07/04/2022 - 10/30/2026

Analytical breakdowns for Pacira BioSciences

- stock quotes and analyst forecast:
Stock Price Pacira|PCRX - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Pacira Pharmaceuticals|PCRX - Enterprise Value
- book capitalization information:
Net Assets per Single Share Pacira BioSciences|PCRX - Accounting Value of Company|Market Value to Book Value Ratio pacira.com|PCRX - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Pacira BioSciences|PCRX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Pacira BioSciences, Inc.|PCRX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Pacira Pharmaceuticals|PCRX - Long-Term Debt|Company Current Liabilities Pacira BioSciences|Quick Ratio pacira.com
- company profitability and valuation multiples indicators:
PCRX - Final Profit
Fundamental valuation:PCRX Pacira
Brand item of Pacira Pharmaceuticals

The robotization of sterile production lines for non-opioid analgesics at Pacira BioSciences (PCRX) requires significant capital expenditures, which directly impacts the structure of short-term liabilities. Analyzing the current level of short-term capital load, an investor assesses the ratio of quick loans to equity, where a stable coefficient confirms financing resilience and protects against market volatility, while stagnation may signal a decline in return on investment efficiency.

Competitors of Pacira BioSciences (PCRX)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|ARS Corp (SPRY) - Current Liabilities to Capital|TBPH: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity eXoZymes EXOZ|ORMP (Oramed) - Current Liabilities to Equity|Entera Bio Corp - Short-Term Debt to Capital|HYFT - Short-Term Debt to Capital|ABVC: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio cumberlandpharma.com|QNTM (Quantum BioPharma) - Short-Term Debt to Capital|FibroGen Inc (FGEN) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Telomir Pharma (TELO)|RANI (ranitherapeutics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital SNYR (Synergy CHC)|Short-Term Debt to Capital Rallybio Corp RLYB|LEXX: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital PULM (Pulmatrix Inc)|PTHL: Short-Term Debt to Capital|APM (Aptorum Group) - Short-Term Debt to Equity|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|impactbiomedinc.com (IBO) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity TNF Pharmaceuticals (TNFA)|YCBD - Current Liabilities to Capital|Short-Term Debt to Equity PainReform Limited PRFX|Short-Term Debt to Capital Coefficient Altamira Therapeutics Ltd (CYTO)|Lipella Pharmaceuticals - Short-Term Debt to Capital|optinose.com (OPTN) - Short-Term Debt to Equity Ratio|PIRS: Short-Term Debt to Capital|PROC - Short-Term Debt to Capital Coefficient|PTPI (Petros) - Short-Term Debt to Capital|Current Liabilities to Capital Qilian International Corp QLI|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|tffpharma.com - Short-Term Debt to Capital Ratio